Respimat from Boehringer Ingelheim is now the first and only inhaler to be awarded the Ease of Use Commendation by the Arthritis Foundation. This award identifies products that make life easier for ...

Active ingredients of dual-action Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol now delivered by new propellant-free inhaler RIDGEFIELD, Conn., Oct. 10, 2011 /PRNewswire/ - ...

Tiotropium delivered at a dose of 5 μg with the Respimat inhaler showed efficacy similar to that of 18 μg of tiotropium delivered with the HandiHaler inhalation device in placebo-controlled trials ...

RIDGEFIELD, Conn., May 26, 2015 -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily STIOLTO™ RESPIMAT® (tiotropium bromide and olodaterol) ...

Striverdi Respimat (olodaterol) inhalation spray The FDA has approved Striverdi Respimat (olodaterol; Boehringer Ingelheim) inhalation spray for the treatment of patients with chronic obstructive ...

Tiotropium as Asthma Add-On Treatment Shows Promise Boehringer Ingelheim announced that the Food and Drug Administration (FDA) has approved Spiriva Respimat (tiotropium bromide) inhalation spray for ...

SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...

Qualcomm is working with German drug giant Boehringer Ingelheim to develop a secure, Internet-connected inhaler to make sure patients with chronic obstructive pulmonary disease, or COPD, are taking ...

-- Patients to Benefit From Easy-to-Use Inhaler With Enhanced Drug Delivery Boehringer Ingelheim and Pfizer today announced successful completion of the approval process for authorisation to market ...

Boehringer Ingelheim has teamed up with ‘wireless health’ specialist Qualcomm to improve patient adherence in chronic obstructive pulmonary disease (COPD). The collaboration looks to develop a ...

U.S. study finds 'excess number of deaths' after major study A mist inhaler used to improve breathing in people with lung diseases including chronic bronchitis and emphysema could increase the risk of ...

Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved Striverdi ® Respimat ® (olodaterol) Inhalation Spray 5 mcg as a long-term, once-daily maintenance ...